These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15851341)

  • 21. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biphasic defibrillation using a single capacitor with large capacitance: reduction of peak voltages and ICD device size.
    Block M; Hammel D; Böcker D; Borggrefe M; Budde T; Isbruch F; Scheld HH; Breithardt G
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):207-14. PubMed ID: 8834690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defibrillation thresholds with right pectoral implantable cardioverter defibrillators and impact of waveform tuning (the Tilt and Tune trial).
    Varma N; Schaerf R; Kalbfleisch S; Pimentel R; Kroll MW; Oza A
    Europace; 2017 Nov; 19(11):1810-1817. PubMed ID: 27986795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal strength and number of shocks at upper limit of vulnerability testing required to predict high defibrillation threshold without inducing ventricular fibrillation.
    Takami K; Yoshida A; Fukuzawa K; Takei A; Kiuchi K; Kanda G; Kumagai H; Takami M; Torii-Tanaka S; Itoh M; Imamura K; Fujiwara R; Suzuki A; Nakanishi T; Yamashita S; Matsumoto A; Hirata K
    Circ J; 2013; 77(10):2490-6. PubMed ID: 23877733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reproducibility of the effectiveness of defibrillation for terminating induced ventricular fibrillation using intraoperatively measured defibrillation threshold energy in patients with implanted cardioverter-defibrillator].
    Jung J; Neuzner J; Himmrich E; Vester E; Michel U; Fries R; Pitschner H; Liebrich A; Ganschow U; Heisel A
    Z Kardiol; 1998 Dec; 87(12):971-7. PubMed ID: 10025070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiological effects of monophasic and biphasic stimuli in normal and infarcted dogs.
    Wharton JM; Richard VJ; Murry CE; Dixon EG; Reimer KA; Meador J; Smith WM; Ideker RE
    Pacing Clin Electrophysiol; 1990 Sep; 13(9):1158-72. PubMed ID: 1700392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual-coil vs single-coil active pectoral implantable defibrillator lead systems: defibrillation energy requirements and probability of defibrillation success at multiples of the defibrillation energy requirements.
    Schulte B; Sperzel J; Carlsson J; Schwarz T; Ehrlich W; Pitschner HF; Neuzner J
    Europace; 2001 Jul; 3(3):177-80. PubMed ID: 11467457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator.
    Zienciuk A; Lubiński A; Królak T; Lewicka-Nowak E; Kempa M; Pazdyga A; Raczak G
    Kardiol Pol; 2007 May; 65(5):495-500; discussion 501-2. PubMed ID: 17577846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative reproducibility of defibrillation threshold and upper limit of vulnerability.
    Swerdlow CD; Davie S; Ahern T; Chen PS
    Pacing Clin Electrophysiol; 1996 Dec; 19(12 Pt 1):2103-11. PubMed ID: 8994950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distal right ventricular coil position reduces defibrillation thresholds.
    Rashba EJ; Bonner M; Wilson J; Shorofsky SR; Peters RW; Gold MR
    J Cardiovasc Electrophysiol; 2003 Oct; 14(10):1036-40. PubMed ID: 14521655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefit of millisecond waveform durations for patients with high defibrillation thresholds.
    Denman RA; Umesan C; Martin PT; Forbes RN; Kroll MW; Anskey EJ; Burnett HE
    Heart Rhythm; 2006 May; 3(5):536-41. PubMed ID: 16648057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immediate reproducibility of upper limit of vulnerability measurements in patients undergoing transvenous implantable cardioverter defibrillator implantation.
    Ellenbogen KA; Wood MA; Gilligan DM; Crofts T; London W; McClish D
    J Cardiovasc Electrophysiol; 1998 Jun; 9(6):588-95. PubMed ID: 9654223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system.
    Rashba EJ; Shorofsky SR; Brown T; Peters RW; Gold MR
    Heart Rhythm; 2005 Jan; 2(1):49-54. PubMed ID: 15851265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardioverter-defibrillator implantations without thoracotomy: clinical experience with various electrode configurations and defibrillation wave forms of an endocardial/subcutaneous defibrillator system].
    Neuzner J; Huth C; Friedl A; Reinisch P; Pitschner HF; Schlepper M
    Z Kardiol; 1993 Feb; 82(2):99-107. PubMed ID: 8465572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Achieving sufficient safety margins with fixed duration waveforms and the use of multiple time constants.
    Keane D; Aweh N; Hynes B; Sheahan RG; Cripps T; Bashir Y; Zaidi A; Fahy G; Lowe M; Doherty P; Kroll MK
    Pacing Clin Electrophysiol; 2007 May; 30(5):596-602. PubMed ID: 17461867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of the upper limit of vulnerability during defibrillator implantation can substitute defibrillation threshold measurement.
    Bessho R; Tanaka S
    Int J Artif Organs; 1998 Mar; 21(3):151-60. PubMed ID: 9622114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
    Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
    Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions.
    Glikson M; Gurevitz OT; Trusty JM; Sharma V; Luria DM; Eldar M; Shen WK; Rea RF; Hammill SC; Friedman PA
    Am J Cardiol; 2004 Dec; 94(11):1445-9. PubMed ID: 15566924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute defibrillation performance of a novel, non-transvenous shock pathway in adult ICD indicated patients.
    Lieberman R; Havel WJ; Rashba E; DeGroot PJ; Stromberg K; Shorofsky SR
    Heart Rhythm; 2008 Jan; 5(1):28-34. PubMed ID: 18053770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ICD waveform optimization: a randomized, prospective, pair-sampled multicenter study.
    Mouchawar G; Kroll M; Val-Mejias JE; Schwartzman D; McKenzie J; Fitzgerald D; Prater S; Katcher M; Fain E; Syed Z
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1992-5. PubMed ID: 11139975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.